J. Kelly Ganjei
Chairman
Inmune Bio, Inc. (INMB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About J. Kelly Ganjei
J. Kelly Ganjei is recorded as Chairman at Inmune Bio, Inc. (INMB). Inmune Bio, Inc. reported in an 8-K filed June 17, 2026 that J. Kelly Ganjei was appointed Director, effective June 16, 2026. Inmune Bio, Inc. reported in an 8-K filed June 10, 2025 that J. Kelly Ganjei was appointed Director, effective June 10, 2025. Inmune Bio, Inc. reported in an 8-K filed June 1, 2023 that J. Kelly Ganjei was appointed Director, effective June 1, 2023.
“Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company's stockholders and until his or her successor is elected and qualified.”
“Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company's stockholders and until his or her successor is elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2016-01-01–present
-
2016-01-01–2025-04-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inmune Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Moss CEO, Board Member
- Cory Ellspermann Board Member
- David Moss Board Member
- Edgardo Baracchini, PhD Board Member
- James Sapirstein Board Member
- Marcia Allen Board Member
- Mark Lowdell Board Member
- R. Duane Clark II Board Member
- Raymond J. Tesi, MD Board Member
- Scott Juda Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.